These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 8396634)
1. Chronic kappa opioid receptor antagonism produces supersensitivity to U-50,488H at the hypothalamo-pituitary-adrenocortical (HPA) axis level. Alcaraz C; Milanés MV; Vargas ML J Pharmacol Exp Ther; 1993 Sep; 266(3):1385-9. PubMed ID: 8396634 [TBL] [Abstract][Full Text] [Related]
2. Chronic naloxone treatment induces supersensitivity to a mu but not to a kappa agonist at the hypothalamus-pituitary-adrenocortical axis level. Alcaraz C; Vargas ML; Fuente T; Milanés MV J Pharmacol Exp Ther; 1993 Sep; 266(3):1602-6. PubMed ID: 8396640 [TBL] [Abstract][Full Text] [Related]
3. Involvement of kappa-opioid receptor mechanisms in the calcitonin-induced potentiation of opioid effects at the hypothalamus-pituitary-adrenocortical axis. Milanés MV; Vargas ML; Martín MI Eur J Pharmacol; 1994 Dec; 271(1):103-9. PubMed ID: 7698193 [TBL] [Abstract][Full Text] [Related]
4. Chronic administration of U50,488H fails to produce hypothalamo-pituitary-adrenal axis tolerance in neonatal rats. Ignar DM; Windh RT; Kuhn CM Neuropharmacology; 1992 Feb; 31(2):143-8. PubMed ID: 1553027 [TBL] [Abstract][Full Text] [Related]
5. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration. Wilson JL; Nayanar V; Walker JS Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441 [TBL] [Abstract][Full Text] [Related]
6. Ontogeny of mu- and kappa-opiate receptor control of the hypothalamo-pituitary-adrenal axis in rats. Adamson WT; Windh RT; Blackford S; Kuhn CM Endocrinology; 1991 Aug; 129(2):959-64. PubMed ID: 1649751 [TBL] [Abstract][Full Text] [Related]
7. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides. Iyengar S; Kim HS; Wood PL Brain Res; 1987 Dec; 435(1-2):220-6. PubMed ID: 2892574 [TBL] [Abstract][Full Text] [Related]
8. Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat. Ignar DM; Kuhn CM J Pharmacol Exp Ther; 1990 Dec; 255(3):1287-95. PubMed ID: 2175800 [TBL] [Abstract][Full Text] [Related]
9. kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor. Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH J Pharmacol Exp Ther; 1996 May; 277(2):877-84. PubMed ID: 8627570 [TBL] [Abstract][Full Text] [Related]
10. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists. Millan MJ; Morris BJ; Herz A J Pharmacol Exp Ther; 1988 Nov; 247(2):721-8. PubMed ID: 2846827 [TBL] [Abstract][Full Text] [Related]
11. Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis. Alcaraz C; Vargas ML; Milanés MV Neuropeptides; 1996 Feb; 30(1):29-36. PubMed ID: 8868296 [TBL] [Abstract][Full Text] [Related]
12. The stimulation of central kappa opioid receptors decreases male sexual behavior and locomotor activity. Leyton M; Stewart J Brain Res; 1992 Oct; 594(1):56-74. PubMed ID: 1334765 [TBL] [Abstract][Full Text] [Related]
13. Serotonergic mechanisms involved in calcitonin potentiation of kappa-opioid receptor-mediated effects on adrenal secretion. Ormazábal MJ; Milanés MV; Martín MI Eur J Pharmacol; 1997 Dec; 340(1):81-7. PubMed ID: 9527510 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade. Pugsley MK; Penz WP; Walker MJ; Wong TM Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979 [TBL] [Abstract][Full Text] [Related]
15. Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat. Iyengar S; Kim HS; Wood PL J Pharmacol Exp Ther; 1986 Aug; 238(2):429-36. PubMed ID: 3016237 [TBL] [Abstract][Full Text] [Related]
16. Effects of U-50,488H and U-50,488H withdrawal on catecholaminergic neurons of the rat hypothalamus. Laorden ML; Milanés MV Life Sci; 2000 Jan; 66(9):803-15. PubMed ID: 10698355 [TBL] [Abstract][Full Text] [Related]
17. Effects of acute and chronic administration of dizocilpine on the pharmacological responses to U-50,488H and brain and spinal cord kappa-opioid receptors in the rat. Bhargava HN; Matwyshyn GA; Gudehithlu KP Pharmacology; 1995 Nov; 51(5):323-30. PubMed ID: 8584584 [TBL] [Abstract][Full Text] [Related]
18. Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat. Diop L; Rivière PJ; Pascaud X; Junien JL Eur J Pharmacol; 1994 Dec; 271(1):65-71. PubMed ID: 7698213 [TBL] [Abstract][Full Text] [Related]
19. Opioid modulation of the fetal hypothalamic-pituitary-adrenal axis: the role of receptor subtypes and route of administration. Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH J Pharmacol Exp Ther; 1997 Apr; 281(1):129-35. PubMed ID: 9103489 [TBL] [Abstract][Full Text] [Related]
20. Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus. Laorden ML; Castells MT; Martínez MD; Martínez PJ; Milanés MV Endocrinology; 2000 Apr; 141(4):1366-76. PubMed ID: 10746640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]